Abeona Therapeutics Inc. (ABEO)
NASDAQ: ABEO · Real-Time Price · USD
5.12
-0.08 (-1.54%)
At close: Feb 27, 2026, 4:00 PM EST
5.19
+0.07 (1.37%)
After-hours: Feb 27, 2026, 7:30 PM EST
Abeona Therapeutics Revenue
Abeona Therapeutics had revenue of $400.00K in the twelve months ending September 30, 2025.
Revenue (ttm)
$400.00K
Revenue Growth
n/a
P/S Ratio
693.65
Revenue / Employee
$2,941
Employees
136
Market Cap
277.46M
Revenue Chart
Revenue History
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Puma Biotechnology | 228.37M |
| Fennec Pharmaceuticals | 38.79M |
| Alector | 21.05M |
| Opus Genetics | 14.63M |
| AC Immune | 5.48M |
| Inhibikase Therapeutics | 1.00 |
| Adlai Nortye | -1.35M |
ABEO News
- 19 days ago - Abeona Therapeutics® Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 2 months ago - Abeona Therapeutics® Announces Appointment of Mohamad Tabrizi as Chief Business Officer - GlobeNewsWire
- 2 months ago - Abeona Therapeutics® Announces New Qualified Treatment Center for ZEVASKYN® in Texas - GlobeNewsWire
- 2 months ago - Abeona Therapeutics® Announces First Patient Treatment with ZEVASKYN® Gene Therapy - GlobeNewsWire
- 3 months ago - Abeona Therapeutics Q3 2025: Strong Financials And Zevaskyn Launch Ahead - Seeking Alpha
- 3 months ago - Abeona Therapeutics Inc. (ABEO) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Abeona Therapeutics® Reports Third Quarter 2025 Financial Results and Corporate Updates - GlobeNewsWire
- 4 months ago - Abeona Therapeutics® Announces Date of Third Quarter Financial Results and Upcoming Investor Conference Participation - GlobeNewsWire